| 期 |
栏目 |
标题 |
文件 |
| 卷 78, 编号 2 (2003) |
Editorial |
Clinical and prognostic implications of gastrointestinal tract lesions in systemic vascular purpuras |
|
| 卷 78, 编号 6 (2003) |
Editorial |
Ischemic disease of the kidneys |
|
| 卷 78, 编号 9 (2003) |
Editorial |
General clinical aspects of the "difficult diagnosis" problem |
|
| 卷 79, 编号 6 (2004) |
Editorial |
Cardiorenai interactions: ciinicai indications and roie in pathogenesis of cardiovascular and renal diseases |
|
| 卷 79, 编号 6 (2004) |
Editorial |
Hyperhomocysteinemia and acute phase proteins in various forms of ischemic heart disease |
|
| 卷 79, 编号 9 (2004) |
Editorial |
Chronic progressive nephropathies and modern lifestyle |
|
| 卷 79, 编号 8 (2004) |
Editorial |
Vasaprostan treatment of fibrosing alveolitis in patients withpulmonary hypertension |
|
| 卷 79, 编号 9 (2004) |
Editorial |
Role of the studyof urinary molecular mediators of immune inflammationand renal fibrosis in chronic glomerulonephritis |
|
| 卷 80, 编号 6 (2008) |
Editorial |
The key stage in development of nephrology research in Russia (The 50th anniversary of the book Nephritides by E.M. Tareev) |
|
| 卷 80, 编号 8 (2008) |
Editorial |
Cardiorenal syndrome in ischemic renal disease (atherosclerotic renovascular hypertension) |
|
| 卷 80, 编号 8 (2008) |
Editorial |
Acute renal failure caused by cholesterol embolism of the intrarenal arteries after coronaroangiography: success of glucocorticosteroid treatment |
|
| 卷 81, 编号 3 (2009) |
Editorial |
Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role |
|
| 卷 81, 编号 8 (2009) |
Editorial |
Renin as a target of direct pharmacological block in arterial hypertension |
|
| 卷 82, 编号 6 (2010) |
Editorial |
Evidence-based medicine in nephrology |
|
| 卷 82, 编号 6 (2010) |
Editorial |
Association of obstructive sleep apnea syndrome with the signs of non-alcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome |
|
| 卷 83, 编号 6 (2011) |
Editorial |
Hyperuricemia as a component of cardiorenal syndrome |
|
| 卷 83, 编号 6 (2011) |
Editorial |
The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients |
|
| 卷 84, 编号 6 (2012) |
Editorial |
PERSONIFICATED MEDICINE IN CLINICAL NEPHROLOGY |
|
| 卷 84, 编号 6 (2012) |
Editorial |
CLINICOPATHOGENETIC CHARACTERISTICS OF CARDIORENAL SYNDROME IN NON-ALCOHOLIC FATTY DISEASE OF THE LIVER |
|
| 卷 84, 编号 6 (2012) |
Editorial |
REMODELING OF CARDIOVASCULAR SYSTEM AND DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME AND OBESITY: ROLE OF GENES ENOS, SUBUNIT P22-PHOX OF NADPH-OXIDASE AND MTHFR |
|
| 卷 84, 编号 6 (2012) |
Editorial |
CHANGES IN RHEOLOGICAL BLOOD PROPERTIES IN PATIENTS WITH LUPUS NEPHRITIS AND IGA-NEPHROPATHY |
|
| 卷 84, 编号 11 (2012) |
Editorial |
Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma |
|
| 卷 85, 编号 6 (2013) |
Editorial |
Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases |
|
| 卷 85, 编号 6 (2013) |
Editorial |
New markers of cardio-renal links in chronic kidney disease |
|
| 卷 85, 编号 5 (2013) |
Editorial |
Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases |
|
| 卷 85, 编号 6 (2013) |
Editorial |
Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity |
|
| 卷 85, 编号 8 (2013) |
Editorial |
Teaching therapeutic disciplines: vectors of modernization |
|
| 卷 86, 编号 4 (2014) |
Editorial |
Clinical diagnosis progress and continuing medical education |
|
| 卷 86, 编号 1 (2014) |
Editorial |
The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease |
|
| 卷 86, 编号 6 (2014) |
Editorial |
Chronic kidney disease and vascular dementia |
|
| 卷 86, 编号 4 (2014) |
Editorial |
Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease |
|
| 卷 86, 编号 4 (2014) |
Editorial |
Endothelial dysfunction gene polymorphisms and the rate of liver fibrosis in chronic hepatitis C |
|
| 卷 86, 编号 6 (2014) |
Editorial |
Clinical significance of serum and urinary biomarkers for water-salt metabolism in patients with proteinuric forms of chronic glomerulonephritis |
|
| 卷 86, 编号 6 (2014) |
Editorial |
Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus |
|
| 卷 86, 编号 12-2 (2014) |
Editorial |
Morphological verification of renal lesion as a compulsory stage in the diagnosis of Fabry disease |
|
| 卷 86, 编号 12-2 (2014) |
Editorial |
Поражение сердца при системных васкулитах: патогенетические звенья, значение факторов риска развития сердечно-сосудистых осложнений и диагностика |
|
| 卷 87, 编号 4 (2015) |
Editorial |
Better diagnosis is an obligatory condition for improving medical care quality |
|
| 卷 87, 编号 3 (2015) |
Editorial |
Clinical value of surfactant protein D as a biomarker of pulmonary fibrosis in patients with scleroderma systematica in relation to the presence of gastroesophageal reflux |
|
| 卷 87, 编号 6 (2015) |
Editorial |
Acute glomerulonephritis in the 21st century |
|
| 卷 87, 编号 6 (2015) |
Editorial |
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease |
|
| 卷 87, 编号 6 (2015) |
Editorial |
Impact of interleukin-10 and interleukin-28 gene polymorphisms on the development and course of lupus nephritis |
|
| 卷 87, 编号 6 (2015) |
Editorial |
Urinary excretion of angiogenesis regulatory factors and renal injury markers in chronic glomerulonephritis: Significance in the assessment of progression |
|
| 卷 88, 编号 4 (2016) |
Editorial |
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease |
(Rus)
|
| 卷 88, 编号 6 (2016) |
Editorial |
Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum |
(Rus)
|
| 卷 88, 编号 6 (2016) |
Editorial |
Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease: A new direction of cardionephroprotection |
(Rus)
|
| 卷 88, 编号 8 (2016) |
Editorial |
Role of polymorphic markers for the genes of hemostasis and platelet receptors in liver fibrosis progression in patients with chronic hepatitis C |
(Rus)
|
| 卷 89, 编号 5 (2017) |
Editorial |
Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment |
(Rus)
|
| 卷 89, 编号 8 (2017) |
Editorial |
Giant cell arteritis: Genetic and epigenetic aspects |
(Rus)
|
| 卷 89, 编号 12 (2017) |
Editorial |
Role of neutrophil dysfunction in the pathogenesis of systemic lupus erythematosus |
|
| 卷 90, 编号 3 (2018) |
Editorial |
Clinical significance of the determination of surfactant proteins A and D in assessing the activity of lung sarcoidosis |
(Rus)
|
| 卷 91, 编号 2 (2019) |
Editorial |
Prediction of features of the course of chronic hepatitis C using Bayesian networks |
(Rus)
|
| 卷 91, 编号 2 (2019) |
Editorial |
Risk factors of unfavorable prognosis of chronic hepatitis C |
(Rus)
|
